511 related articles for article (PubMed ID: 16289744)
1. Dietary flavonoids: effects on xenobiotic and carcinogen metabolism.
Moon YJ; Wang X; Morris ME
Toxicol In Vitro; 2006 Mar; 20(2):187-210. PubMed ID: 16289744
[TBL] [Abstract][Full Text] [Related]
2. Chemopreventive and therapeutic modulation of green tea polyphenols on drug metabolizing enzymes in 4-Nitroquinoline 1-oxide induced oral cancer.
Srinivasan P; Suchalatha S; Babu PV; Devi RS; Narayan S; Sabitha KE; Shyamala Devi CS
Chem Biol Interact; 2008 Apr; 172(3):224-34. PubMed ID: 18336807
[TBL] [Abstract][Full Text] [Related]
3. [Effects of the flavonoids on cytochrome P-450 CYP1, 2E1, 3A4 and 19].
Zheng J; Zhou HH
Yao Xue Xue Bao; 2007 Jan; 42(1):8-12. PubMed ID: 17520800
[TBL] [Abstract][Full Text] [Related]
4. Drug-metabolizing enzymes: mechanisms and functions.
Sheweita SA
Curr Drug Metab; 2000 Sep; 1(2):107-32. PubMed ID: 11465078
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of dietary flavonoids on drug metabolizing and antioxidant enzymes in female rat.
Breinholt V; Lauridsen ST; Dragsted LO
Xenobiotica; 1999 Dec; 29(12):1227-40. PubMed ID: 10647909
[TBL] [Abstract][Full Text] [Related]
6. Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues.
Toussaint C; Albin N; Massaad L; Grunenwald D; Parise O; Morizet J; Gouyette A; Chabot GG
Cancer Res; 1993 Oct; 53(19):4608-12. PubMed ID: 8402635
[TBL] [Abstract][Full Text] [Related]
7. Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450.
Hodek P; Trefil P; Stiborová M
Chem Biol Interact; 2002 Jan; 139(1):1-21. PubMed ID: 11803026
[TBL] [Abstract][Full Text] [Related]
8. Modification of hepatic drug-metabolizing enzymes in rats treated with alkyl sulfides.
Siess MH; Le Bon AM; Canivenc-Lavier MC; Suschetet M
Cancer Lett; 1997 Dec; 120(2):195-201. PubMed ID: 9461037
[TBL] [Abstract][Full Text] [Related]
9. Differential modulation of xenobiotic metabolizing enzymes by vanadium during diethylnitrosamine-induced hepatocarcinogenesis in Sprague-Dawley rats.
Chakraborty A; Selvaraj S
Neoplasma; 2000; 47(2):81-9. PubMed ID: 10985472
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of flavonoids and model inducers on drug-metabolizing enzymes in rat liver.
Canivenc-Lavier MC; Vernevaut MF; Totis M; Siess MH; Magdalou J; Suschetet M
Toxicology; 1996 Nov; 114(1):19-27. PubMed ID: 8931757
[TBL] [Abstract][Full Text] [Related]
11. Modulation of phase I and phase II xenobiotic-metabolizing enzymes by selenium-enriched garlic in rats.
Ip C; Lisk DJ
Nutr Cancer; 1997; 28(2):184-8. PubMed ID: 9290126
[TBL] [Abstract][Full Text] [Related]
12. Impact of dioxin-type induction of drug-metabolizing enzymes on the metabolism of endo- and xenobiotics.
Schrenk D
Biochem Pharmacol; 1998 Apr; 55(8):1155-62. PubMed ID: 9719469
[TBL] [Abstract][Full Text] [Related]
13. Differences in the expression of xenobiotic-metabolizing enzymes between islets derived from the ventral and dorsal anlage of the pancreas.
Standop J; Ulrich AB; Schneider MB; Büchler MW; Pour PM
Pancreatology; 2002; 2(6):510-8. PubMed ID: 12435863
[TBL] [Abstract][Full Text] [Related]
14. Multienzyme-mediated stable and transient multidrug resistance and collateral sensitivity induced by xenobiotics.
Rekha GK; Sladek NE
Cancer Chemother Pharmacol; 1997; 40(3):215-24. PubMed ID: 9219504
[TBL] [Abstract][Full Text] [Related]
15. Regulation of phase II enzymes by genistein and daidzein in male and female Swiss Webster mice.
Froyen EB; Reeves JL; Mitchell AE; Steinberg FM
J Med Food; 2009 Dec; 12(6):1227-37. PubMed ID: 20041775
[TBL] [Abstract][Full Text] [Related]
16. Transcript profiling of enzymes involved in detoxification of xenobiotics and reactive oxygen in human normal and simian virus 40 T antigen-immortalized oral keratinocytes.
Vondracek M; Weaver DA; Sarang Z; Hedberg JJ; Willey JC; Wärngård L; Grafström RC
Int J Cancer; 2002 Jun; 99(6):776-82. PubMed ID: 12115477
[TBL] [Abstract][Full Text] [Related]
17. Effect of dietary constituents with chemopreventive potential on adduct formation of a low dose of the heterocyclic amines PhIP and IQ and phase II hepatic enzymes.
Dingley KH; Ubick EA; Chiarappa-Zucca ML; Nowell S; Abel S; Ebeler SE; Mitchell AE; Burns SA; Steinberg FM; Clifford AJ
Nutr Cancer; 2003; 46(2):212-21. PubMed ID: 14690798
[TBL] [Abstract][Full Text] [Related]
18. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes.
Ahn D; Putt D; Kresty L; Stoner GD; Fromm D; Hollenberg PF
Carcinogenesis; 1996 Apr; 17(4):821-8. PubMed ID: 8625497
[TBL] [Abstract][Full Text] [Related]
19. Effects of baicalein and wogonin on drug-metabolizing enzymes in C57BL/6J mice.
Ueng YF; Shyu CC; Lin YL; Park SS; Liao JF; Chen CF
Life Sci; 2000 Sep; 67(18):2189-200. PubMed ID: 11045600
[TBL] [Abstract][Full Text] [Related]
20. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
